Medicine focus

Categories
  1. What types of cancer can toripalimab treat?

    Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?

    Read more »
  2. Can erdafitinib treat breast cancer? The latest data, in simple terms.

    Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

    Read more »
  3. When is toripalimab getting its EMA approval (and how not to wait)

    Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.

    Read more »
  4. Tivdak's EMA approval: When is it coming (and what to do if you can't wait)

    When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.

    Read more »
  5. Zynyz's EMA approval: When will the treatment be available (and how not to wait)

    Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.

    Read more »
  6. Erdafitinib's EMA approval: Where are we five years after its first global approval

    Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?

    Waiting for erdafitinib's EMA approvalWaiting for erdafitinib's EMA approval
    Read more »
  7. What types of cancer can tazemetostat treat? The latest research.

    Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.

    Read more »
  8. Tazemetostat's EMA approval: What if waiting is no option?

    Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.

    Read more »
  9. Tofersen's EMA approval: When is it coming (and how to get the medicine in the meantime)

    Get the latest updates on Tofersen's EMA approval timeline and discover alternative ways to access the medicine in the meantime.

    Read more »
  10. Relyvrio's elusive approval in Europe: How to skip the wait

    What does Relyvrio's recent EMA rejection mean for ALS patients in Europe? All you need to know (and what you can do to get the treatment quickly)

    Read more »
  11. Edaravone in Europe: How to get this ALS treatment quickly

    When will Radicut/Radicava(edaravone) be available to ALS patients in Europe and the UK (and what to do in the meantime).

    Read more »
  12. Tyrvaya: When is the first nasal spray for dry eyes coming to Europe?

    When is the first nasal spray for dry eyes coming to Europe (and what to do in the meantime)

    Read more »
  13. Roflumilast Cream in Europe: Approval timelines, efficacy and more

    Topical roflumilast isn't likely to be available in Europe soon. Here's what you can expect, and some solutions for the meantime.

    Read more »
  14. Adagrasib and brain metastases: Does it work, is it better than sotorasib, and how to get it?

    How effective is adagrasib for brain metastases? The latest data, and how to access the treatment quickly.

    Read more »
  15. Is Elahere approved in Europe (and what to do until it is)?

    When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.

    Read more »
  16. Can I get lecanemab in the UK? MHRA approval timelines and how to avoid waiting.

    When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.

    Read more »
  17. Ryzneuta's EMA approval: When is it coming (and how to avoid waiting)

    Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.

    Read more »
  18. Capivasertib's EMA approval: When is it coming, and what to do in the meantime?

    When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.

    Read more »
  19. When will nitrogacestat get its EMA approval (and how to access it earlier)

    Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.

    Read more »
  20. When Enhertu stops working: What causes it and what comes after?

    What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.

    Read more »
  21. Enhertu vs Herceptin: What is the difference between these HER2-mutated cancer treatments?

    How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.

    Read more »
  22. Can Opzelura be used on children? Here's everything we know.

    What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.

    Read more »
  23. Margetuximab's EMA approval: When is it coming, and how to avoid waiting?

    When is margetuximab's EMA and MHRA approval expected? And what are your options in the meantime?

    Read more »
  24. Repotrectinib in Europe: When is the novel ROS1-positive lung cancer treatment coming?

    Is reportrectinib getting EMA approval soon, and how can you access it in the meantime?

    Read more »
  25. Fruquintinib as a lung cancer treatment: Are we there yet?

    How effective is fruquintinib for lung cancer? The latest clinical trial results, and what they could mean for your treatment.

    Read more »
  26. What is the fastest migraine relief medicine in Europe and the UK? [2023 Update]

    What is the fastest migraine relief medicine that you can get in Europe and the UK in 2023?

    Read more »
  27. Fruquintinib EMA approval: When is it coming and what to do in the meantime?

    When can colorectal cancer patients in Europe and the UK expect to have access to Fruzaqla?

    Read more »
  28. When will momelotinib be approved in Europe and the UK?

    When will Ojjaara be available to myelofibrosis patients in Europe and the UK? And what you can do in the meantime.

     

     

    Read more »
  29. When will Vamorolone be available in Europe and the UK? The full story.

    What patients in Europe and the UK need to know about vamorolone's availability timeline.

    Read more »
  30. When will Zavzpret be available in the UK (and what to do in the meantime)?

    When will Zavegepant be available in the UK (and what to do in the meantime)

    Read more »
Page
US 0